AnaBios
PrivateLast Round
M&A
Apr 4, 2023
Total Funding Raised
$12.5M
Company Overview
AnaBios operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Private Equity round in June 2022.
AnaBios is a biotechnology company that provides drug discovery services using its proprietary human-focused translational technologies to establish the safety and efficacy of novel compounds before clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnaBios Comparables
Compare AnaBios with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ncardia | 84% | |
| Revalia Bio | 79% | |
| Clyde Biosciences | 78% |
For institutional investors. Book with your work email.
AnaBios Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 4, 2023 | ||||
| Private Equity | Jun 7, 2022 | ||||
| Grant | Sep 30, 2021 | ||||
| Series B | Dec 27, 2016 | ||||
| Series A | Apr 5, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AnaBios Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Neurological Disorders and Stroke | Grant |
| TCA Venture Group | Series A |
| Principia SGR | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors increased 118% MoM.
- Nov 8, 2025
Monthly visitors grew 50% MoM, reaching 5.1K.
For institutional investors. Book with your work email.
AnaBios Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AnaBios's valuation, stock price, and market status.
Is AnaBios a public or private company?
AnaBios is a private company.
What is the current stock price of AnaBios?
AnaBios is a private company, so its shares have no public market price. Caplight tracks AnaBios's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AnaBios worth (valuation)?
Valuation information for AnaBios is not publicly available.
Can I buy AnaBios stock?
AnaBios shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AnaBios's last funding round?
AnaBios's most recent funding round was M&A on April 4, 2023.
Who are the main investors in AnaBios?
Key investors in AnaBios include National Institute of Neurological Disorders and Stroke, Principia SGR.
Will AnaBios IPO soon?
No public IPO plans have been announced for AnaBios.
How can I track AnaBios secondary market activity?
Caplight tracks bids, offers, and trades in AnaBios's shares on secondary markets.